The battle against VIM-producing Pseudomonas aeruginosa in Intensive Care Units (ICUs) is growing more complex as the bacteria not just sustains but flourishes. The presence of this pathogen in ICUs, the hidden risk of colonization in unexpected places and an alarming mortality rate exceeding 30% necessitates stringent and proactive management strategies. Environmental controls, recognition of risk factors and surveillance strategies must be redoubled to disrupt this pathogen’s biofilm cycle and prevent potential outbreaks.
Pseudomonas aeruginosa is a notorious contributor to hospital-acquired infections (HAIs), causing 13% to 19% of such incidents annually in the U.S. The bacterium is capable of resisting various antibiotics and thriving in inhospitable environments, an attribute especially observable in strains carrying the Verona integron–encoded metallo-β-lactamase (VIM). The enzyme confers resistance to carbapenems, usually the last line of antibiotic therapy.
The prevalence of VIM-positive P aeruginosa (VIM-PA) in ICUs is a growing concern due to the incidence of serious infections with mortality rates often surpassing 30%. Various factors like the complex nature of clinical cases managed within ICUs, along with therapeutic procedures implemented in these settings, can provide an encouraging environment for P aeruginosa. Certain predisposing factors may even enable silent colonization till it triggers clinical decline or transmission to other patients.
Effective guidelines for infection prevention and outbreak management require a thorough understanding of specific risk factors that lead to VIM-PA colonization and infection. This article endeavors to spotlight environmental, patient-related, and provider-related issues within ICUs that spur the growth of these superbugs.
Several environmental risk factors within the ICU contribute to VIM-PA colonization and infection. Persistent environmental contamination by P aeruginosa was identified as a principal source of bacterial transmission in a retrospective study conducted in the Netherlands. Routine disinfection protocols are sometimes inadequate against P aeruginosa due to its virulence and antimicrobial resistance patterns, particularly in biofilm formation. The ability to adhere to surfaces and perpetuate biofilms makes numerous high-touch surfaces within the ICU potential reservoirs for VIM-producing Pseudomonas aeruginosa. These include countertops, medical trolleys, ventilator buttons, bed rails, infusion stands, and specialty medical equipment. This highlights the need for rigorous sterilization or replacement of such devices to prevent persistent infection sources.
Among other risk factors, sink drains and water systems provide the ideal environment for P aeruginosa to thrive, often leading to outbreaks in hospitals. Staff and visitor movements also contribute to horizontal transmission due to high patient-to-nurse ratios, poor hand hygiene, non-adherence to personal protective equipment protocols, and inadequate infection control measures enforced for visitors.
Furthermore, patient-related risk factors include prior antibiotic use, past hospitalizations, old age, anemia, severity and length of illness, and specific clinical conditions. Invasive procedures and prolonged hospital stays, medical predispositions, and special care environments like neonatal ICUs where improper handling of expressed breast milk can lead to bacterial colonization all amplify the risk of VIM-PA infections.
Consequently, it is imperative to employ effective infection prevention and control measures to disrupt the growth of lurking disease-causing organisms within the ICU. Vigilance, understanding of risks, and taking proactive, comprehensive steps are key in combating the proliferation of VIM-PA.